Literature DB >> 29847456

Trace of survivin in cancer.

Fereshteh Shojaei1, Farshad Yazdani-Nafchi1, Mehdi Banitalebi-Dehkordi1, Mohammad Chehelgerdi1, Milad Khorramian-Ghahfarokhi2.   

Abstract

Survivin is one of the most cancer-specific proteins overexpressed in almost all malignancies, but is nearly undetectable in most normal tissues in adults. Functionally, as a member of the inhibitor of apoptosis family, survivin has been shown to inhibit apoptosis and increase proliferation. The antiapoptotic function of survivin seems to be related to its ability to inhibit caspases directly or indirectly. Furthermore, the role of survivin in cell cycle division control is related to its role in the chromosomal passenger complex. Consistent with its determining role in these processes, survivin plays a crucial role in cancer progression and cancer cell resistance to anticancer drugs and ionizing radiation. On the basis of these findings, recently survivin has been investigated intensively as an ideal tumor biomarker. Thus, multiple molecular approaches such as use of the RNA interfering technique, antisense oligonucleotides, ribozyme, and small molecule inhibitors have been used to downregulate survivin regulation and inhibit its biological function consequently. In this review, all these approaches are explained and other compounds that induced apoptosis in different cell lines through survivin inhibition are also reported.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29847456     DOI: 10.1097/CEJ.0000000000000453

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  11 in total

1.  Anticancer Properties of Probiotic Saccharomyces boulardii Supernatant on Human Breast Cancer Cells.

Authors:  Babak Pakbin; Shaghayegh Pishkhan Dibazar; Samaneh Allahyari; Maryam Javadi; Zahra Amani; Alireza Farasat; Sina Darzi
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-30       Impact factor: 4.609

2.  CDCA8 Contributes to the Development and Progression of Thyroid Cancer through Regulating CDK1.

Authors:  Cheng Xiang; Wu-Hui Sun; You Ke; Xing Yu; Yong Wang
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

3.  Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.

Authors:  Liang Chen; Yarong Song; Teng Hou; Xuexiang Li; Lulin Cheng; Yunxue Li; Yifei Xing
Journal:  J Exp Clin Cancer Res       Date:  2022-06-03

4.  Influence of Paclitaxel and Doxorubicin Therapy of ßIII-Tubulin, Carbonic Anhydrase IX, and Survivin in Chemically Induced Breast Cancer in Female Rat.

Authors:  Alena Pastornická; Silvia Rybárová; Slávka Drahošová; Jozef Mihalik; Andrea Kreheľová; Andriana Pavliuk-Karachevtseva; Ingrid Hodorová
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

5.  miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib.

Authors:  Leisheng Wang; He En; Lei Yang; Yanbing Zhang; Baisheng Sun; Jianjiang Gao
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

Review 6.  Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer.

Authors:  James A Radosevich; Michael Babich
Journal:  Onco Targets Ther       Date:  2019-11-06       Impact factor: 4.147

7.  Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer.

Authors:  Xiaoxi Zhu; Renyu Zhou; Yuanzhi Lu; Ying Zhang; Qiang Chen; Yin Li
Journal:  Front Oncol       Date:  2021-11-03       Impact factor: 6.244

8.  Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Christian Vay; Shahrooz Babaei; Sami-Alexander Safi; Levent Dizdar; Alexander Rehders; Lena Haeberle; Christoph Roderburg; Sven H Loosen; Irene Esposito; Wolfram T Knoefel; Andreas Krieg
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

9.  Identification of Pivotal Genes and Pathways in Osteoarthritic Degenerative Meniscal Lesions via Bioinformatics Analysis of the GSE52042 Dataset.

Authors:  Xu Huan; Ying Jinhe; Zheng Rongzong
Journal:  Med Sci Monit       Date:  2019-11-23

10.  Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients.

Authors:  Franziska Büscheck; Mariam Sulimankhil; Nathaniel Melling; Doris Höflmayer; Claudia Hube-Magg; Ronald Simon; Cosima Göbel; Andrea Hinsch; Sören Weidemann; Jacob R Izbicki; Frank Jacobsen; Tim Mandelkow; Niclas C Blessin; Christina Möller-Koop; Florian Lutz; Florian Viehweger; Katharina Möller; Guido Sauter; Maximillian Lennartz; Eike Burandt; Patrick Lebok; Sarah Minner; Sarah Bonk; Hartwig Huland; Markus Graefen; Thorsten Schlomm; Christoph Fraune
Journal:  Cancer Med       Date:  2020-01-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.